| name | ata-postop-pituitary-axis-surveillance |
| description | Recommends retesting all pituitary axes starting at 6 weeks after pituitary surgery and periodically to monitor development or resolution of pituitary deficiencies. Use when managing postoperative pituitary surgery patient; triggers include postoperative pituitary surgery patient needing longitudinal hormone monitoring. |
Conduct periodic pituitary axis testing starting 6 weeks post-pituitary surgery
STEP 1 — Gather Information
Collect date of pituitary surgery, type of surgery, preoperative pituitary function if available, current medications (especially glucocorticoids), symptoms of hormone deficiency (fatigue, hypotension, polyuria, cold intolerance, menstrual changes, etc.), and any prior postoperative hormone results. If surgery date is <6 weeks ago, defer testing and schedule reassessment at 6 weeks post-op.
STEP 2 — Rule In / Rule Out
Is the patient at least 6 weeks post-pituitary surgery? If yes, proceed to step 3; if no, delay testing until the 6-week mark and reevaluate then.
STEP 3 — Classify or Stratify
Determine which pituitary axes to assess based on surgical extent and preoperative deficits: order basal morning cortisol (or ACTH stim if on glucocorticoids), free T4 and TSH, IGF-1, gonadotropins (LH, FSH, estradiol/testosterone), prolactin, and consider serum/urine osmolarity if polyuria present. Action: Obtain the indicated hormone panel.
STEP 4 — Decide
If any axis reveals deficiency, initiate appropriate hormone replacement and schedule repeat testing in 3–6 months; if all axes are normal, repeat testing annually or as clinically indicated based on symptoms.
Clinical Guardrails / Mimics / Pitfalls
Do not interpret cortisol while patient is on glucocorticoids without adequate washout (at least 18–24h after last HC dose or longer for synthetic GCs); avoid testing during acute illness or stress; do not rely solely on TSH to diagnose central hypothyroidism; recognize that transient diabetes insipidus may resolve postoperatively and avoid unnecessary DDAVP; consider that estrogen therapy can elevate total cortisol via CBG, masking AI.
Concrete Clinical Example
A 45-year-old woman 8 weeks post-transsphenoidal resection of a nonfunctioning adenoma presents with fatigue and mild polyuria. Morning cortisol 8 µg/dL (low), free T4 low-normal with normal TSH, IGF-1 low, LH/FSH low with low estradiol. Diagnosed with central AI, CH, GHD, and hypogonadism; started on hydrocortisone, levothyroxine, GH replacement, and estrogen. Repeat testing scheduled in 3 months.
Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, https://doi.org/10.1210/jc.2016-2118
